Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 1021–1040 of 17,529 recalls

October 24, 2024· Unexo Life Sciences Private Limited

Recalled Item: CHEEKY BONSAI PAIN RELIEF PATCHES

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2024· Unexo Life Sciences Private Limited

Recalled Item: ABSORBINE JR PAIN RELIEVING KNEE PATCH

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 24, 2024· Unexo Life Sciences Private Limited

Recalled Item: HealthWise PERIOD PATCH Menstrual Pain Relief

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 23, 2024· Lupin Pharmaceuticals Inc.

Recalled Item: Ramipril Capsules USP 10 mg

The Issue: CGMP Deviations: Active pharmaceutical ingredient was sourced from

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 23, 2024· Lupin Pharmaceuticals Inc.

Recalled Item: Ramipril Capsules USP 2.5 mg

The Issue: CGMP Deviations: Active pharmaceutical ingredient was sourced from

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 23, 2024· Lupin Pharmaceuticals Inc.

Recalled Item: Ramipril Capsules USP 5 mg

The Issue: CGMP Deviations: Active pharmaceutical ingredient was sourced from

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 23, 2024· Cipla USA, Inc.

Recalled Item: Lanthanum Carbonate Chewable Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 23, 2024· Cipla USA, Inc.

Recalled Item: Lanthanum Carbonate Chewable Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 22, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Morphine Sulfate Extended-Release Tablets 15 mg

The Issue: Failed Impurities/Degradation Specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 22, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Morphine Sulfate Extended-Release Tablets 30 mg

The Issue: Failed Impurities/Degradation Specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 21, 2024· BLI International, Inc.

Recalled Item: Chlorpheniramine Maleate 4 mg tablets

The Issue: Superpotent Drug: Stability failure for assay at 6

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 18, 2024· AvKARE

Recalled Item: Sunitinib Malate Capsules

The Issue: Labeling: Label Mix-Up

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 18, 2024· AvKARE

Recalled Item: Sunitinib Malate Capsules

The Issue: Labeling: Label Mix-Up

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 17, 2024· Keystone Industries

Recalled Item: Perio Maintenance Rinse 0.63% Stannous Fluoride Concentrated Solution

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 15, 2024· Akron Pharma, Inc.

Recalled Item: OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 11, 2024· Padagis US LLC

Recalled Item: Triamcinolone Acetonide Cream USP

The Issue: Subpotent and Superpotent Drug. Out of specification assay

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 10, 2024· ACCORD HEALTHCARE, INC.

Recalled Item: Cinacalcet Tablets

The Issue: CGMP Deviations: the presence of a nitrosamine impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 10, 2024· ACCORD HEALTHCARE, INC.

Recalled Item: Cinacalcet Tablets

The Issue: CGMP Deviations: the presence of a nitrosamine impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 10, 2024· ACCORD HEALTHCARE, INC.

Recalled Item: Cinacalcet Tablets 30 mg

The Issue: CGMP Deviations: the presence of a nitrosamine impurity,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 10, 2024· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-Release Capsules

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund